Aberrant RHEB/mTORC1 signaling has been linked to many overgrowth diseases including Lymphangioleiomymoatosis (LAM), Tuberous Sclerosis (TS), Peutz-Jeghers syndrome (PJS) and benign tumor formation [20–22]. This evidence concerns the gene RHEB and Peutz-Jeghers syndrome.